Sometimes NAD is listed as NAD, NADH or NAD+ IV therapy. So what’s the difference? Know how to get these therapy drips from the Toronto Functional Medicine Centre.
POSTED ON SEPTEMBER 20, 2022 BY TORONTO FUNCTIONAL MEDICINE CENTRE
If you have low energy levels or a fuzzy memory, NAD IV therapy from our Toronto clinic could provide support.
This is a type of IV therapy drip is a type that’s been gaining attention for fostering an improvement in energy levels, cellular functioning, tissue repair, anti-aging effects, and other health benefits.
NAD is a coenzyme that has several roles in the human body. It’s known for promoting DNA repair, transforming the food we eat into energy, optimizing cognition, cell health and muscle health, and regulating sleep-wake cycles.
“The cofactor nicotinamide adenine dinucleotide (NAD) is an important metabolic regulator of cellular redox reactions and a co-factor or a co-substrate for key enzymes essential for normal cellular function in different tissues,” further explains a piece from Pharmaceuticals.
We can all agree that the body needs NAD to thrive and function. But on the down side, these levels naturally lessen as we age, which is why we might experience age-related issues through the years, such as forgetfulness.
So how can we replenish our levels to reach optimal health and possibly delay age-related diseases? At the Toronto Functional Medicine Centre, NAD IV therapy is offered to our patients, combined with sublingual supplements to help sustain optimum NAD levels. Read on to see if the oral intake of precursors and sublingual delivery, merged with an NAD IV vitamin drip therapy, is fitting for your health goals.
Who Should Consider This IV Drip Treatment
According to Frontiers in Aging Neuroscience, “Accumulating evidence suggests that active maintenance of optimal levels of …. (NAD+) is beneficial in conditions of either increased NAD+ turnover or inadequate synthesis, including Alzheimer’s disease and other neurodegenerative disorders and the aging process.”
Because it has an impact on improved brain function, cell vitality and cellular energy, NAD could potentially support these health concerns:
Accordingly, NAD IV therapy may be considered as a support for helping fine-tune body functions. It might also assist with replenishing neurotransmitters and improving cognition, especially if you’re suffering from brain fog.
If you think NAD IV therapy drips might be advantageous to your health, please talk to us! Our functional medicine providers can customize your intravenous drips with NAD-boosting molecules.
Whether your goal is to improve mental performance on the job, to boost energy levels, or support post chronic illness recovery, we’re ready to listen with compassionate care.
Learn About Our IV therapy and Functional Medicine Treatments
Our IV therapy lounge is dedicated to holistic wellness, which is why we’d like to welcome you as a new patient!
When combined with lifestyle modifications and other treatments, intravenous therapy could provide you with various health benefits. Offering freshly compounded, customized vitamin drip treatments, our menu includes an array of essential vitamins and minerals: vitamin C, amino acid building blocks, glutamic acid, folic acid, glutathione IV, and other vitamin infusions.
The Toronto Functional Medicine Centre focuses on integrative and functional medicine, which allows us to treat each patient as a unique entity. Due to our integrative approach to health care, we inspire patients to follow through with their wellness treatment for optimal functioning. Our functional medicine treatments can be applied to a range of health concerns, including chronic and acute care, immune function, blood pressure issues, thyroid conditions, nutritional deficiencies, and skin vitality.
Do you want to prevent memory loss and avoid brain fog? NAD IV therapy from our Toronto clinic could provide beneficial effects to your wellness. Click here to contact us for information about our IV therapy and functional medicine programs.
Disclaimer: The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.
Blum, Kenneth; Braverman, Eric R; Holder, Jay M; Lubar, Joel F; Monastra, Vincent J; Miller, David & Comings, David E (November 2000). Reward Deficiency Syndrome: A Biogenetic Model for the Diagnosis and Treatment of Impulsive, Addictive, and Compulsive Behaviors. Journal of Psychoactive Drugs 32 (Supplement): i–iv, 1–112.
Blum K, Downs BW, Dushaj K, Li M, Braverman ER, Fried L, Waite R, Demotrovics Z, Badgaiyan RD. THE BENEFITS OF CUSTOMIZED DNA DIRECTED NUTRITION TO BALANCE THE BRAIN REWARD CIRCUITRY AND REDUCE ADDICTIVE BEHAVIORS. Precis Med (Bangalore). 2016;1(1):18-33. Epub 2016 Aug 1. PMID: 28066828; PMCID: PMC5210211.
Blum, Kenneth; Noble, Ernest; Peter J. Sheridan; Anne Montgomery; Terry Ritchie; Pudur Jagadeeswaran; Harou Nogami; Arthur H. Briggs; Jay B. Cohn (April 18, 1990). Allelic Association of Human Dopamine D2 Receptor Gene in Alcoholism. Journal of the American Medical Association 263 (15): 2055–60.
Blum K, Oscar-Berman M, Stuller E, et al. Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms. 2012;3(5):139-. doi:10.4172/2155-6105.1000139.
Braidy N, Villalva MD, van Eeden S. Sobriety and Satiety: Is NAD+ the Answer? Antioxidants (Basel). 2020 May 14;9(5):425. doi: 10.3390/antiox9050425. PMID: 32423100; PMCID: PMC7278809.
Brown MT, Bellone C, Mameli M, Labouèbe G, Bocklisch C, Balland B, Dahan L, Luján R, Deisseroth K, Lüscher C. Drug-driven AMPA receptor redistribution mimicked by selective dopamine neuron stimulation. PLoS One. 2010 Dec 31;5(12):e15870. doi: 10.1371/journal.pone.0015870. PMID: 21209835; PMCID: PMC3013137.
Cleary, JP. A Consideration of Niacin as an Inhibitor of the Predatory Response. Journal of Orthomolecular Medicine Vol. 18, No. 1, 2003.
Dimitrijević I., Popović N., Sabljak V., Škodrić-Trifunović V., Dimitrijević N. Food addiction-diagnosis and treatment. Psychiatr. Danub. 2015;27:101–106.
Grant R, Berg J, Mestayer R, Braidy N, Bennett J, Broom S, Watson J. A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD. Front Aging Neurosci. 2019 Sep 12;11:257. doi: 10.3389/fnagi.2019.00257. PMID: 31572171; PMCID: PMC6751327.
Miller M, Chen AL, Stokes SD, et al. Early Intervention of Intravenous KB220IV- Neuroadaptagen Amino-Acid Therapy (NAAT)TM Improves Behavioral Outcomes in a Residential Treatment Program: A Pilot Study. Journal of psychoactive drugs. 2012;44(5):398-409.
NAD+ metabolism in health and disease. Peter Belenky, Katrina L. Bogan, Charles Brenner. Trends Biochem Sci. 2007 Jan; 32(1): 12–19. Published online 2006 Dec 11. doi: 10.1016/j.tibs.2006.11.006
National Institute on Drug Abuse (http://www.drugabuse.gov). Updated March 2017.
“Nicotinamide Riboside: Benefits, Side Effects and Dosage” from Healthline, By Ryan Raman, MS, RD on December 10, 2018, viewed on Sept. 9, 2022.
Radenkovic D, Reason, Verdin E. Clinical Evidence for Targeting NAD Therapeutically. Pharmaceuticals (Basel). 2020 Sep 15;13(9):247. doi: 10.3390/ph13090247. PMID: 32942582; PMCID: PMC7558103.
Shirayama Y, Chaki S. Neurochemistry of the Nucleus Accumbens and its Relevance to Depression and Antidepressant Action in Rodents. Current Neuropharmacology. 2006;4(4):277-291.
S. Owen, M.D., P. Norris, M.Ed., LPC, DAPA, S. Broom Gibson, Ph.D., R. Mestayer, M.D. Neurotransmitter Restoration Therapy for the Treatment of Substance Abuse. Presentation at Society for Neuroscience annual meeting, Nov. 2008.
Riegel AC, Kalivas PW. Neuroscience: Lack of inhibition leads to abuse. Nature. 2010 Feb 11;463(7282):743-4. doi: 10.1038/463743a. PMID: 20148025; PMCID: PMC6451657.
The NAD Deficiency Diseases. John P. Cleary, M.D.1. Journal of Orthomolecular Medicine Vol. 1, No. 3. 2937 Monroe Street Madison, WI 53711.
Valenzuela CF. Alcohol and neurotransmitter interactions. Alcohol Health Res World. 1997;21(2):144-8. PMID: 15704351; PMCID: PMC6826822.